NC BERD Seminar: Common Variants Influence Immunotherapy Response

NC BERD Seminar: Machine Learning for Precise Diagnostics and Therapeutics

The Carter Lab develops and applies computational approaches to aid the interpretation of genetic variation and to advance precision cancer medicine. A major focus of the lab is on joint analysis of tumor and inherited genomes to uncover the role of genetic background in shaping cancer risk, somatic tumor evolution and therapeutic response. Her recent work investigates how the inherited immune system affects tumor genome evolution and the characteristics of the tumor immune microenvironment to identify opportunities and barriers for immunotherapy.

Speaker:
Hannah Carter, MEng, PhD
Associate Professor
Department of Medicine, Division of Genomics and Precision Medicine
University of California at San Diego

This event is sponsored by Duke University Departments of Computational Biology and Bioinformatics (CBB) and Biostatistics and Bioinformatics, the Duke Center for Genomic and Computational Biology (GCB), the Precision Genomics Collaboratory, and the Duke University School of Medicine. It is being cross-promoted by the North Carolina BERD Consortium (Duke University School of Medicine, University of North Carolina-Chapel Hill, and Wake Forest School of Medicine).